Wednesday, October 1, 2008

James K Happ...no mention , once again. Wonder why?

Once again, no mention of the ex-executive who will be last to go on trial in this 'Larger than Enron' case. Last?

After everyone involved, including the President of this company? Why last?
is everyione aware of the origin of this ex-executive? James K Happ...the ex-employee of Richard Rainwater. Never mentioned by any 'reporter'. I wonder why?

Tuesday, September 30, 2008 - 1:54 PM EDT |
Modified: Tuesday, September 30, 2008 - 2:01 PM
Poulsen trial kicks off WednesdayBusiness First of Columbus - by Kevin Kemper


The president of what was once the nation’s largest financier of physician practices and other health-care firms is scheduled to go on trial Wednesday for what the government calls the nation’s largest corporate fraud at a private company.

Lance Poulsen, a founder and former chairman of Dublin-based National Century Financial Enterprises Inc., will stand trial in U.S. District Court in Columbus on charges that he defrauded investors out of nearly $3 billion dollars. The government has charged the 65-year-old Poulsen with one count each of conspiracy, wire fraud and money laundering conspiracy, four counts of concealment of money laundering and six counts of securities fraud. He has pleaded not guilty to all the charges.

Poulsen is the sixth National Century executive to stand trial. The five who went before him were found guilty of similar charges by a jury in March and are serving prison sentences ranging from five to 15 years.

The criminal trial that begins Oct. 1 will be Poulsen’s second. Another federal jury in Columbus found Poulsen guilty in March of attempting to bribe Sherry Gibson, a former National Century executive scheduled to testify against him. U.S. District Court Judge Algenon Marbley, who is handling all the National Century criminal cases, sentenced Poulsen to 10 years in prison and a $17,500 fine. Demmler has not yet been sentenced.

National Century was a financier for health-care providers, specializing in buying their receivables at a discount for quick cash. It then packaged the receivables as asset-backed bonds and sold them to investors. The Dublin company collapsed into bankruptcy in 2002, forcing other medical businesses to fail and prompting the U.S. Justice Department to begin looking into the company’s failure.

Poulsen’s trial begins 9 a.m. Wednesday with jury selection. The trial is expected to last several weeks.

No comments: